Good news for patients with locally advanced and metastatic (when the cancer cells spread from the place where they first formed to another part of the body) basal cell carcinoma (BCC). The FDA has approved cemiplimab-rwlc (Libtayo®; Regneron Pharmaceuticals, Inc. and...
